SIH Partners’s AbbVie ABBV Stock Holding History

SIH Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,506	Closed	-$1.85M	–	322
2026 Q1	$1.85M	Buy	+8,506	New	+$1.89M	0.02%	143
2025 Q4	–	Sell	-1,831	Closed	-$424K	–	208
2025 Q3	$424K	Buy	+1,831	New	+$373K	0.01%	172
2025 Q2	–	Sell	-16,449	Closed	-$3.45M	–	157
2025 Q1	$3.45M	Buy	+16,449	New	+$3.2M	0.12%	64

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIH Partners's ABBV Position: Q2 2026 in Review

SIH Partners sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 8,506 shares — an estimated $1.85M sold.

SIH Partners first reported a position in ABBV in Q1 2025 and held it in 3 quarters. The position peaked at $3.45M in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

SIH Partners reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
SIH Partners sold 8,506 AbbVie shares in Q2 2026, an estimated $1.85M.
SIH Partners first reported a position in AbbVie in Q1 2025 and held it in 3 quarters.
SIH Partners's AbbVie position peaked at $3.45M in Q1 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.